For investors attempting to adjust their portfolios in anticipation of a recession by the end of 2020, recent economic indicators carry a message: they may have to prepare for the downturn to start as early as 2019 despite stocks enjoying a recent “dead-cat bounce.” Bloomberg News reports that a Federal Reserve Bank of New York gauge puts the chances of ...

The world enters 2019 with a lot more uncertainty about the prospects for global growth. The excitement a year ago about a synchronised pickup in global growth is replaced by angst that was initially focused on China and Europe but is increasingly spreading to the US, the sole consistent bright spot and one of the most powerful job creators and ...

There may be such a thing as a free lunch in China’s pharmaceutical industry. It turns out it’s not an unlimited buffet, though. For years, the country’s largest drugmakers have happily sold low-cost generic medicines yielding gross margins of 80 percent to 90 percent without giving much thought to consumer protection or innovation. It’s not uncommon for pharma companies to ...